INVEGA Side Effects

7022405-5 | Anxiety, Asthma, Blood Calcium Increased, Dizziness, Dyspnoea, Gastrointestinal Disorder, Hypotension, Musculoskeletal Stiffness
on Sep 22, 2010 Female patient from GERMANY , weighting 194.0 lb, was diagnosed with pruritus and was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), asthma (What is asthma?), blood calcium increased, dizziness (What is dizziness?), dyspnoea, gastrointestinal disorder, hypotension, musculoskeletal stiffness. Invega dosage: . During the same period patient was treated with METYSOLON (View Metysolon Review and Metysolon Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), CALCIUM (View Calcium Review and Calcium Label ), PREDNITOP (View Prednitop Review and Prednitop Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).

7022190-7 | Compartment Syndrome, Extremity Necrosis, Leg Amputation, Neuroleptic Malignant Syndrome, Rhabdomyolysis
Patient was taking Invega (View Usage). Patient had the following side effects: compartment syndrome, extremity necrosis, leg amputation, neuroleptic malignant syndrome, rhabdomyolysis on Aug 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Invega dosage: . During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), SINGULAIR (View Singulair Review and Singulair Label ), CATAPRES (View Catapres Review and Catapres Label ), LITHIUM (View Lithium Review and Lithium Label ). Patient was hospitalized and became disabled.

7020761-5 | Galactorrhoea
Adverse event was reported on Sep 13, 2010 by a Female patient taking Invega (View Usage) (Dosage: ) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: UNITED STATES , 36 years of age, After Invega was administered, patient had the following side effects: galactorrhoea.

7020428-3 | Epilepsy
on Sep 20, 2010 Female patient from EL SALVADOR , 19 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?). Invega dosage: . During the same period patient was treated with DIPHENYLHYDANTOIN (View Diphenylhydantoin Review and Diphenylhydantoin Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ).


7020427-1 | Constipation
on Sep 21, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with schizophrenia and was treated with Invega (View Usage). Patient had the following side effects: constipation (What is constipation?). Invega dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ).

7020168-0 | Galactorrhoea
Patient was taking Invega (View Usage). After Invega was administered, patient had the following side effects: galactorrhoea on Aug 27, 2010 from UNITED STATES Additional patient health information: Female patient , 26 years of age, . Invega dosage: .

7020167-9 | Treatment Noncompliance
Adverse event was reported on Aug 30, 2010 by a Female patient taking Invega (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: UNITED STATES , weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: treatment noncompliance. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), DEPAKOTE (View Depakote Review and Depakote Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), RISPERDAL CONSTA (View Risperdal Consta Review and Risperdal Consta Label ).

7018555-X | Erection Increased, Paranoia
on Sep 01, 2010 Male patient from UNITED STATES , 20 years of age, weighting 140.0 lb, was diagnosed with schizophrenia and was treated with Invega (View Usage). Patient had the following side effects: erection increased, paranoia. Invega dosage: .

7018301-X | Blood Cholesterol Increased, Blood Prolactin Increased, Breast Discharge, Hypoglycaemia, Low Density Lipoprotein Increased
on Aug 13, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with schizophrenia and was treated with Invega (View Usage). After Invega was administered, patient had the following side effects: blood cholesterol increased, blood prolactin increased, breast discharge, hypoglycaemia, low density lipoprotein increased. Invega dosage: .

7018000-4 | Abnormal Behaviour, Extrapyramidal Disorder, Freezing Phenomenon, Hot Flush, Loss Of Control Of Legs, Muscle Disorder, Overdose, Pain, Tremor
Patient was taking Invega (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, extrapyramidal disorder, freezing phenomenon, hot flush, loss of control of legs, muscle disorder (What is muscle disorder?), overdose, pain (What is pain?), tremor on Sep 27, 2010 from UNITED STATES Additional patient health information: Male patient , 26 years of age, weighting 197.0 lb, . Invega dosage: .

7015781-0 | Diarrhoea, Gingival Discolouration, Loss Of Consciousness
Adverse event was reported on Sep 16, 2010 by a Male patient taking Invega (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: UNITED STATES , weighting 165.0 lb, Patient had the following side effects: diarrhoea, gingival discolouration, loss of consciousness. During the same period patient was treated with COGENTIN (View Cogentin Review and Cogentin Label ).

7012551-4 | Galactorrhoea
on Aug 23, 2010 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with schizophrenia and was treated with Invega (View Usage). After Invega was administered, patient had the following side effects: galactorrhoea. Invega dosage: .

7012529-0 | Mood Altered
on Aug 24, 2010 Male patient from UNITED STATES , weighting 157.0 lb, was diagnosed with depression (What is depression?), bipolar disorder (What is bipolar disorder?), gastric disorder, irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: mood altered. Invega dosage: . During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), ATIVAN (View Ativan Review and Ativan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DICYCLOMINE (View Dicyclomine Review and Dicyclomine Label ).

7012440-5 | Condition Aggravated, Hallucination, Auditory
Patient was taking Invega (View Usage). Patient had the following side effects: condition aggravated, hallucination, auditory on Aug 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 145.0 lb, was diagnosed with schizophrenia and. Invega dosage: .

7012438-7 | Somnolence
Adverse event was reported on Aug 16, 2010 by a Male patient taking Invega (View Usage) (Dosage: ) was diagnosed with delusion and. Location: UNITED STATES , weighting 160.0 lb, After Invega was administered, patient had the following side effects: somnolence. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

7012432-6 | Anxiety, Asthma, Blood Calcium Increased, Dizziness, Dyspnoea, Gastrointestinal Disorder, Hypotension, Musculoskeletal Stiffness
on Sep 17, 2010 Female patient from GERMANY , weighting 194.0 lb, was diagnosed with pruritus and was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), asthma (What is asthma?), blood calcium increased, dizziness (What is dizziness?), dyspnoea, gastrointestinal disorder, hypotension, musculoskeletal stiffness. Invega dosage: . During the same period patient was treated with METYSOLON (View Metysolon Review and Metysolon Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), CALCIUM (View Calcium Review and Calcium Label ), PREDNITOP (View Prednitop Review and Prednitop Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).

7012431-4 | Vomiting
on Aug 04, 2010 Male patient from UNITED STATES , 17 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Invega (View Usage). Patient had the following side effects: vomiting. Invega dosage: .

7006181-8 | Coma, Hypertension, Hypotonia, Miosis, Ventricular Fibrillation
Patient was taking Invega (View Usage). After Invega was administered, patient had the following side effects: coma, hypertension, hypotonia, miosis, ventricular fibrillation on Sep 10, 2010 from ITALY Additional patient health information: Female patient , 65 years of age, . Invega dosage: .

7005169-0 | Delirium, Hyponatraemia, Polydipsia
Adverse event was reported on Sep 10, 2010 by a Male patient taking Invega (View Usage) (Dosage: ) . Location: GERMANY , 50 years of age, weighting 212.7 lb, Patient experienced the following unwanted or unexpected effects: delirium, hyponatraemia, polydipsia. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), VALPROAT (View Valproat Review and Valproat Label ). Patient was hospitalized.

6988316-6 | Self Injurious Behaviour, Sluggishness
on Sep 07, 2010 Female patient from ITALY , 36 years of age, was treated with Invega (View Usage). Patient had the following side effects: self injurious behaviour, sluggishness. Invega dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), ABILIFY (View Abilify Review and Abilify Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ).

6985803-1 | Epilepsy, Off Label Use
on Sep 06, 2010 Female patient from EL SALVADOR , 19 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Invega (View Usage). After Invega was administered, patient had the following side effects: epilepsy (What is epilepsy?), off label use. Invega dosage: . During the same period patient was treated with DIPHENYLHYDANTOIN (View Diphenylhydantoin Review and Diphenylhydantoin Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ).

6985553-1 | Aggression, Irritability
Patient was taking Invega (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, irritability on Sep 03, 2010 from AUSTRALIA Additional patient health information: Male patient , child 8 years of age, weighting 99.21 lb, was diagnosed with disturbance in social behaviour and. Invega dosage: .

6985552-X | Pain In Jaw
Adverse event was reported on Sep 03, 2010 by a Male patient taking Invega (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?), schizophrenia and. Location: UNITED STATES , weighting 300.0 lb, Patient had the following side effects: pain in jaw. During the same period patient was treated with BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6985551-8 | Aggression, Irritability
on Sep 03, 2010 Male patient from AUSTRALIA , child 11 years of age, was diagnosed with disturbance in social behaviour, bipolar disorder (What is bipolar disorder?) and was treated with Invega (View Usage). After Invega was administered, patient had the following side effects: aggression, irritability. Invega dosage: 3 To 6 Mg Daily.

6980162-2 | Myocardial Infarction, Off Label Use
on Sep 06, 2010 Female patient from TURKEY , 27 years of age, was diagnosed with major depression and was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction, off label use. Invega dosage: .

6972377-4 | Arterial Thrombosis Limb, Blood Creatinine Increased, Depression Suicidal, Off Label Use, Pulmonary Embolism
Patient was taking Invega (View Usage). Patient had the following side effects: arterial thrombosis limb, blood creatinine increased, depression suicidal, off label use, pulmonary embolism (What is pulmonary embolism?) on Sep 03, 2010 from SWITZERLAND Additional patient health information: Male patient , 38 years of age, weighting 249.1 lb, was diagnosed with depression (What is depression?) and. Invega dosage: . During the same period patient was treated with VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ), LITHIOFOR (View Lithiofor Review and Lithiofor Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

6965710-0 | Bradypnoea, Hypotonia Neonatal
Adverse event was reported on Aug 25, 2010 by a Female patient taking Invega (View Usage) (Dosage: ) . Location: SWITZERLAND , weighting 5.67 lb, After Invega was administered, patient had the following side effects: bradypnoea, hypotonia neonatal.

6963474-8 | Condition Aggravated, Off Label Use, Suicidal Ideation
on Aug 23, 2010 Male patient from UNITED STATES , weighting 272.0 lb, was diagnosed with hallucination, delusion and was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, off label use, suicidal ideation. Invega dosage: . During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.

6945119-6 | Thrombocytopenia
on Aug 20, 2010 Male patient from UNITED STATES , 42 years of age, was diagnosed with schizophrenia and was treated with Invega (View Usage). Patient had the following side effects: thrombocytopenia. Invega dosage: .

6940516-7 | Fatigue, Suicide Attempt, Tachycardia
Patient was taking Invega (View Usage). After Invega was administered, patient had the following side effects: fatigue, suicide attempt, tachycardia on Aug 17, 2010 from GERMANY Additional patient health information: Female patient , weighting 187.4 lb, . Invega dosage: . During the same period patient was treated with TAXILAN (View Taxilan Review and Taxilan Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), PIPAMPERONE (View Pipamperone Review and Pipamperone Label ), MELPERON (View Melperon Review and Melperon Label ).

6939216-9 | Agitation, Akathisia, Blood Creatine Phosphokinase Increased, Confusional State, Hypertension, Intentional Overdose, Restlessness, Suicide Attempt, Tachycardia
Adverse event was reported on Aug 13, 2010 by a Female patient taking Invega (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: TURKEY , 24 years of age, Patient experienced the following unwanted or unexpected effects: agitation, akathisia, blood creatine phosphokinase increased, confusional state, hypertension, intentional overdose, restlessness, suicide attempt, tachycardia. Patient was hospitalized.

6936924-0 | Hepatitis Toxic
on Aug 16, 2010 Male patient from SPAIN , 41 years of age, was diagnosed with schizophrenia and was treated with Invega (View Usage). Patient had the following side effects: hepatitis toxic. Invega dosage: . Patient was hospitalized.

6936922-7 | Intentional Overdose, Self Injurious Behaviour
on Aug 15, 2010 Female patient from ITALY , 50 years of age, was treated with Invega (View Usage). After Invega was administered, patient had the following side effects: intentional overdose, self injurious behaviour. Invega dosage: .

6932618-6 | Psychotic Disorder, Treatment Noncompliance
Patient was taking Invega (View Usage). Patient experienced the following unwanted or unexpected effects: psychotic disorder (What is psychotic disorder?), treatment noncompliance on Aug 11, 2010 from UNITED STATES Additional patient health information: Male patient , 40 years of age, was diagnosed with schizophrenia and. Invega dosage: . During the same period patient was treated with INVEGA SUSTENNA (View Invega Sustenna Review and Invega Sustenna Label ). Patient was hospitalized.

6931847-5 | Liver Function Test Abnormal
Adverse event was reported on Jul 22, 2010 by a Male patient taking Invega (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: UNITED STATES , 57 years of age, Patient had the following side effects: liver function test abnormal.

6931767-6 | Anaemia, Neutrophilia
on Aug 09, 2010 Female patient from LEBANON , 33 years of age, was diagnosed with schizophrenia, depression (What is depression?) and was treated with Invega (View Usage). After Invega was administered, patient had the following side effects: anaemia, neutrophilia. Invega dosage: . During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), MAGNE B6 (View Magne- B6 Review and Magne- B6 Label ).

6931372-1 | Treatment Noncompliance
on Jul 15, 2010 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with schizophrenia and was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: treatment noncompliance. Invega dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), DEPAKOTE (View Depakote Review and Depakote Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), RISPERDAL CONSTA (View Risperdal Consta Review and Risperdal Consta Label ).

6931368-X | Intentional Overdose, Self Injurious Behaviour, Sopor
Patient was taking Invega (View Usage). Patient had the following side effects: intentional overdose, self injurious behaviour, sopor on Aug 08, 2010 from ITALY Additional patient health information: Male patient , 46 years of age, . Invega dosage: .

6930413-5 | Cough, Hypersomnia
Adverse event was reported on Jul 21, 2010 by a Female patient taking Invega (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: UNITED STATES , weighting 200.0 lb, After Invega was administered, patient had the following side effects: cough, hypersomnia.

6930091-5 | Dizziness, Malaise, Somnolence, Unevaluable Event, Vomiting
on Aug 17, 2010 Male patient from UNITED STATES , weighting 154.0 lb, was diagnosed with depression (What is depression?) and was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), malaise, somnolence, unevaluable event, vomiting. Invega dosage: 6 Mg. Patient was hospitalized and became disabled.

6922461-6 | Accidental Overdose, Intestinal Dilatation, Intestinal Resection
on Aug 03, 2010 Male patient from UNITED STATES , 75 years of age, weighting 185.2 lb, was diagnosed with schizophrenia and was treated with Invega (View Usage). Patient had the following side effects: accidental overdose, intestinal dilatation, intestinal resection. Invega dosage: . During the same period patient was treated with INVEGA SUSTENNA (View Invega Sustenna Review and Invega Sustenna Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), PEPCID (View Pepcid Review and Pepcid Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6922459-8 | Self Injurious Behaviour, Sluggishness
Patient was taking Invega (View Usage). After Invega was administered, patient had the following side effects: self injurious behaviour, sluggishness on Aug 04, 2010 from ITALY Additional patient health information: Male patient , 28 years of age, . Invega dosage: . During the same period patient was treated with SERENASE (View Serenase Review and Serenase Label ).

6917618-4 | Asthenia, Decreased Appetite, Gait Disturbance, Memory Impairment, Tremor, Weight Decreased
Adverse event was reported on Jul 13, 2010 by a Male patient taking Invega (View Usage) (Dosage: ) was diagnosed with schizoaffective disorder and. Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, decreased appetite, gait disturbance, memory impairment, tremor, weight decreased. During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ).

6911542-9 | Diarrhoea, Gingival Discolouration, Loss Of Consciousness
on Jul 27, 2010 Male patient from UNITED STATES , weighting 165.0 lb, was diagnosed with schizophrenia and was treated with Invega (View Usage). Patient had the following side effects: diarrhoea, gingival discolouration, loss of consciousness. Invega dosage: . During the same period patient was treated with COGENTIN (View Cogentin Review and Cogentin Label ).

6911540-5 | Abnormal Dreams, Erectile Dysfunction, Painful Erection, Palpitations, Sexual Dysfunction
on Jul 08, 2010 Male patient from UNITED STATES , 55 years of age, weighting 152.0 lb, was diagnosed with schizophrenia and was treated with Invega (View Usage). After Invega was administered, patient had the following side effects: abnormal dreams, erectile dysfunction (What is erectile dysfunction?), painful erection, palpitations, sexual dysfunction. Invega dosage: .

6911538-7 | Anxiety, Restlessness
Patient was taking Invega (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), restlessness on Jun 28, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 210.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), depression (What is depression?), anxiety (What is anxiety?), insomnia and. Invega dosage: . During the same period patient was treated with HEROIN (View Heroin Review and Heroin Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ABILIFY (View Abilify Review and Abilify Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), TRAZODONE (View Trazodone Review and Trazodone Label ).

6909162-5 | Blood Prolactin Increased, Blood Testosterone Decreased, Glucose Tolerance Impaired, Gynaecomastia, Hallucination, Auditory, Prostatomegaly, Somnambulism
Adverse event was reported on Jul 27, 2010 by a Male patient taking Invega (View Usage) (Dosage: ) was diagnosed with schizoaffective disorder, bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , weighting 240.0 lb, Patient had the following side effects: blood prolactin increased, blood testosterone decreased, glucose tolerance impaired, gynaecomastia, hallucination, auditory, prostatomegaly, somnambulism. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ).

6909160-1 | Deep Vein Thrombosis
on Aug 02, 2010 Female patient from UNITED STATES , weighting 130.0 lb, was diagnosed with affective disorder, contraception and was treated with Invega (View Usage). After Invega was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Invega dosage: . During the same period patient was treated with SEASONIQUE (View Seasonique Review and Seasonique Label ). Patient was hospitalized.

6906136-5 | Cognitive Disorder, Dysarthria, Speech Disorder
on Aug 03, 2010 Male patient from UNITED STATES , 33 years of age, weighting 200.0 lb, was treated with Invega (View Usage). Patient experienced the following unwanted or unexpected effects: cognitive disorder, dysarthria, speech disorder. Invega dosage: 1 1 Po.

6895131-0 | Acute Pulmonary Oedema, Cardiac Failure, Tachyarrhythmia
Patient was taking Invega (View Usage). Patient had the following side effects: acute pulmonary oedema, cardiac failure, tachyarrhythmia on Jul 22, 2010 from SWITZERLAND Additional patient health information: Male patient , 82 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), depression (What is depression?), atrial fibrillation (What is atrial fibrillation?) and. Invega dosage: . During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.